A world without avoidable cancer deaths.
To achieve early cancer detection, better treatment and less suffering through deep genome intelligence.
Who We Are
We are a genomic medicine company that makes state-of-the-art, ultrasensitive liquid biopsy tests for disease detection and treatment selection. Headquartered in Palo Alto, Lucence provides molecular diagnostic services for innovative cancer testing worldwide through a US federally CLIA-licensed central laboratory.
We see the fight against cancer as a mission. If we can deliver early detection for all cancers to achieve cure, that is something worth our time, our energy, everything.
Join Our Team
Lucence is a precision oncology company with offices in Palo Alto, Singapore, Hong Kong and Suzhou.
We have assembled a dynamic team of physicians, scientists, geneticists, bioinformaticians and data analysts who are passionate about the work we do here to improve cancer care. We come from different backgrounds and nationalities but are focused on a single mission – to fight cancer and save lives.